As a result, researchers theorize that murine models in the Ipamorelin groups could have consumed more food, leading to the observed weight gain
Mr Mfazo Hove Featured in Newsweek: GLP-1 Medications and Vision Loss Posted Medically Reviewed by: Mr Mfazo Hove, Consultant Ophthalmic Surgeon Author: Chris Dunnington Published: July 16, 2026 Last Updated: July 16, 2026 Mr Mfazo Hove, Consultant Ophthalmic Surgeon and Medical Director of Blue Fin Vision, has been invited by Newsweek to comment on new international research linking GLP-1 medications to a rare optic nerve condition that can cause sudden vision loss
Dietitians are experts in food and nutrition who can create a personalized eating plan for you
The semaglutide molecule appears to have stronger effects on appetite centers in the brain, leading to reduced food intake and earlier feelings of fullness during meals
Join IV Drip Membership One IV drip + free B12 shot for $180/month, plus 20% off additional services.